Imidazole Derivative Synthesis via Ionic Liquid Catalysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a growing need for new antimicrobial agents effective against drug-resistant microorganisms, particularly bacteria and fungi, due to increasing resistance to conventional antibiotics, and existing drug discovery methods often involve hazardous solvents and inefficient chemical processes.
Innovation Solution
The synthesis of 4-(2,4,5-tris(4-chlorophenyl)-1H-imidazol-1-yl)butanoic acid via a one-pot four-component reaction using pyridinium ionic liquid as a catalyst and solvent, which demonstrates excellent antimicrobial activity against various microbes, including gram-positive and gram-negative bacteria, and fungi.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antibiotics are used to treat bacterial infections, then existing antimicrobial agents can treat common infections, but they become ineffective against drug-resistant microorganisms
Solution Approach 1:
The patent employs a multi-component reaction system that combines four different reactants (aldehyde, amino acid derivative, beta-dicarbonyl compound, and ammonium salt) to create a complex imidazole derivative structure. This segmented approach to molecular construction allows for systematic variation of structural elements to overcome microbial resistance.
Solution Approach 2:
The patent systematically varies chemical parameters including substituents on the imidazole ring, side chain lengths, and functional groups to generate a library of derivatives with different biological activities. This parameter optimization enables identification of compounds effective against resistant strains.
2Ease of manufacture
If traditional chemical synthesis methods are used, then conventional solvents and catalysts can facilitate reactions, but they generate hazardous substances and require harsh conditions
Solution Approach 1:
The patent uses ionic liquids as intermediary substances that serve dual functions as both solvent and catalyst. These ionic liquids facilitate the multi-component reaction under mild conditions while being environmentally benign, replacing traditional hazardous solvents and catalysts.
Solution Approach 2:
The patent converts the potential harm of using complex multi-component reactions into benefit by employing ionic liquids that simplify the reaction conditions, eliminate the need for multiple purification steps, and reduce waste generation, thereby turning a potentially problematic synthesis into an efficient and green process.
3Productivity
If ultrasound irradiation is used for chemical transformations, then reaction times are shortened and yields are improved, but energy consumption increases
Solution Approach 1:
The patent utilizes ultrasound irradiation to induce mechanical vibration and cavitation in the reaction medium, which enhances mass transfer, breaks down product inhibition, and accelerates the multi-component reaction. This mechanical energy input significantly reduces reaction time from hours to minutes while maintaining mild temperature conditions.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compound exhibits significant antibacterial and antifungal activities, providing a promising therapeutic option for microbial infections while employing a greener, more efficient synthesis method that reduces the use of hazardous solvents and improves reaction yields and purity.
Implementation Method 1
The synthesis of 4-(2,4,5-tris(4-chlorophenyl)-1H-imidazol-1-yl)butanoic acid via a one-pot four-component reaction using pyridinium ionic liquid as a catalyst and solvent
Implementation Method 2
In recent years, there has been a tremendous upsurge of interest in various chemical transformations performed under ultrasound irradiation
Data Source
AI summary
A 4-(2,4,5-tris(4-chlorophenyl)-1H-imidazol-1-yl)butanoic acid compound, its synthesis, and its use as an antimicrobial agent.


